Elsevier

Biological Psychiatry

Volume 55, Issue 10, 15 May 2004, Pages 989-994
Biological Psychiatry

Original article
Pervasive developmental disorder and childhood-onset schizophrenia: comorbid disorder or a phenotypic variant of a very early onset illness?

https://doi.org/10.1016/j.biopsych.2004.01.019Get rights and content

Abstract

Background

Childhood-onset schizophrenia (COS) is a severe form of the adult-onset disorder with a high rate of premorbid developmental abnormalities. Early symptoms of pervasive developmental disorder (PDD) have been reported in five independent studies of COS. In this study, we compared evidence for premorbid PDD as a nonspecific manifestation of impaired neurodevelopment seen in schizophrenia, or as an independent risk factor for COS.

Methods

Diagnosis of past or current autism or PDD was made according to the DSM-IV criteria. COS patients with and without PDD were compared with respect to neuropsychological, clinical, and neurobiological measures. Several candidate genes for autism were examined in the entire COS sample and the subgroup with PDD using the Transmission Disequilibrium Test (TDT) and Quantitative TDT (QTDT).

Results

Nineteen (25%) of COS probands had a lifetime diagnosis of PDD: one met criteria for autism, two for Asperger's disorder, and 16 for PDD not otherwise specified. Premorbid social impairment was most common feature for COS-PDD subjects. The PDD group did not differ from the rest of the COS sample with respect to age of onset, IQ, response to medications, and rate of familial schizotypy. Unexpectedly, two siblings of COS-PDD probands met criteria for nuclear autism. There was no difference between PDD and non-PDD groups with respect to initial brain magnetic resonance imaging (MRI) measures. However, rate of gray matter loss was greater for PDD (n = 12) than for the non-PDD (n = 27) subgroup (−19.5 ± 11.3 mL/year vs. −9.6 ± 15.3 mL/year; p = .05). None of eight candidate genes for autism were associated with COS or COS-PDD.

Conclusions

Premorbid PDD in COS is more likely to be a nonspecific marker of severe early abnormal neurodevelopment. However, the occurrence of two siblings of COS-PDD probands (17%) with nuclear autism remains to be understood.

Section snippets

Subjects

Accrual of subjects for the NIMH childhood-onset schizophrenia study has been described elsewhere (Nicolson and Rapoport 1999). Briefly, children ages 6–18 meeting DSM-III-R/DSM-IV criteria for schizophrenia with onset of psychosis before their 13th birthday were recruited nationally. Diagnostic process was extensive and included detailed review of medical and school records and full-day, in-person interviews with children and their parents using the Schedule for Affective Disorders and

Results

Of 75 COS probands, 19 had a lifetime diagnosis of PDD (25%), of whom 1 met criteria for autism (past and current), 2 for Asperger's disorder (past and current), and 16 for PDD not otherwise specified. Demographic and clinical data for COS patients with and without PDD are presented in Table 2.

In 12 of 19 cases (63%), the diagnosis of PDD was made before patients entered the NIMH study. In most cases (15 of 19; 79%), PDD symptoms had been present before age 3 years; however, four patients had

Discussion

Counter to our expectations, a comorbid lifetime diagnosis of PDD or autism did not predict early age of onset, lower cognitive performance, or poor long-term outcome. In addition, COS-PDD subgroup did not differ from the rest of the COS sample on any of the clinical and neuropsychological measures. Thus, our clinical data do not support a prediction that an autistic subgroup has a unique clinical pattern.

Neurobiologically, the data are complex. The predicted profile of brain abnormalities

References (49)

  • N.C Andreasen

    Scale for the Assessment of Negative Symptoms

    (1983)
  • N.C Andreasen

    Scale for the Assessment of Positive Symptoms

    (1984)
  • J.R Asarnow et al.

    Children with schizophrenia spectrum and depressive disorders: a comparative study of premorbid adjustment, onset pattern and severity of impairment

    (1988)
  • R.F Asarnow et al.

    Childhood-onset schizophreniaEditors' introduction

    Schizophr Bull

    (1994)
  • S.K Berument et al.

    Autism screening questionnaireDiagnostic validity

    Br J Psychiatry

    (1999)
  • H.E Cannon-Spoor et al.

    Measurement of premorbid adjustment in chronic schizophrenia

    Schizophr Bull

    (1982)
  • S Cantor et al.

    Childhood schizophreniaPresent but not accounted for

    Am J Psychiatry

    (1982)
  • D.J Clarke et al.

    Pervasive developmental disorders and psychoses in adult life

    Br J Psychiatry

    (1989)
  • E Courchesne et al.

    Evidence of brain overgrowth in the first year of life in autism

    JAMA

    (2003)
  • E Courchesne et al.

    Unusual brain growth patterns in early life in patients with autistic disorderAn MRI study

    Neurology

    (2001)
  • J Endicott et al.

    A diagnostic interviewThe schedule for affective disorders and schizophrenia

    Arch Gen Psychiatry

    (1978)
  • J.N Giedd et al.

    Brain development during childhood and adolescenceA longitudinal MRI study

    Nat Neurosci

    (1999)
  • W Guy

    Clinical Global Impressions, ECDEU Assessment Manual for Psychopharmacology

    (1976)
  • W.H Green et al.

    Schizophrenia with childhood onset: a phenomenological study of 38 cases

    (1992)
  • Cited by (136)

    • The co-occurrence of autistic spectrum disorder and schizophrenia: A nationwide population-based study

      2021, Journal of Psychiatric Research
      Citation Excerpt :

      Mandell et al. (2012) examined chart review, and performed clinical interviews integrated with social responsiveness scale to assess ASD prevalence, and found a 10% prevalence of ASD among 141 inpatients with various psychiatric diagnoses, yet utilized an uncontrolled population with a small sample (Mandell et al., 2012). Other studies (Sporn et al., 2004; Fraser et al., 2012; Waris et al., 2013) also employed a relatively small sample size, and most of them were uncontrolled. Thus, additional studies are needed in order to establish whether this co-occurrence is significant in rate and prevalence.

    • Genetics of Childhood-onset Schizophrenia 2019 Update

      2020, Child and Adolescent Psychiatric Clinics of North America
    • Autism, Psychosis, or Both? Unraveling Complex Patient Presentations

      2020, Child and Adolescent Psychiatric Clinics of North America
    View all citing articles on Scopus
    View full text